Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary Cohort.

Jessica B KendrickMeijiao ZhouLinda H FicocielloVidhya ParameswaranClaudy Mullon Michael S AngerDaniel W Coyne

Published in: International journal of nephrology and renovascular disease (2022)

Despite evolving treatment patterns, switching to SO resulted in improved sP control with fewer pills per day in this contemporary hemodialysis cohort.

Keyphrases

chronic kidney disease
peritoneal dialysis
end stage renal disease
risk assessment
heavy metals